Abstract

Background Tenofovir is recommended as a first-line therapy in HIV treatment. However, its long term use is associated with proximal tubular injury and renal dysfunction. Tenofovir has been shown to target the proximal tubular mitochondria, resulting in severe mitochondrial injury and overproduction of ROS and RNS. ROS are potent stimuli for the activation of NFB, a key transcription factor, which is known to mediate inflammation.The NFB response proinflammatory genes include iNOS, COX, TNFa, and others such as PARP-1. In the present study, we investigated whether NFB inflammatory signaling pathway plays a role in tenofovir nephrotoxicity.

Highlights

  • Tenofovir is recommended as a first-line therapy in HIV treatment

  • We investigated whether NF-B inflammatory signaling pathway plays a role in tenofovir nephrotoxicity

  • Submit your manuscript to BioMed Central and take full advantage of:

Read more

Summary

Background

Tenofovir is recommended as a first-line therapy in HIV treatment. Its long term use is associated with proximal tubular injury and renal dysfunction. Tenofovir has been shown to target the proximal tubular mitochondria, resulting in severe mitochondrial injury and overproduction of ROS and RNS. ROS are potent stimuli for the activation of NF-B, a key transcription factor, which is known to mediate inflammation.The NF-B response proinflammatory genes include iNOS, COX, TNFa, and others such as PARP-1. We investigated whether NF-B inflammatory signaling pathway plays a role in tenofovir nephrotoxicity. Statistically significant increase in the mRNA and protein expressions of NFkB, and its target proinflammatory genes, iNOS, COX-2, TNF a and PARP-1 as compared with control

Conclusion
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.